BioSpace News Archive

Agreement to screen discovery and early development compounds using artificial intelligence and computational biophysics

-Interim data expected in 1H 2019-

Vik Shah Named COO; Elena Izmailova, Ph.D. Named Chief Scientific Officer; Gol Ophir Named Head of Business Development

More than half (59%) of cancer patients and survivors feel concerned that potential policy changes related to having a pre-existing condition will limit their access to healthcare and insured patients and survivors are concerned they may lose healthcare coverage due to national healthcare policy changes (46%), according to new national survey results from Cancer and Careers,

NorthStar Anesthesia (“NorthStar” or the “Company”), one of the country’s leading anesthesia care providers, today announced the appointment of Adam Spiegel as Chief Executive Officer and Sean L. Richardson as Chief Operating Officer, effective immediately.

Each year, more than 38 million school days are missed by students due to the flu1, and last year’s cold & flu season hit U.S. families especially hard, with a record-breaking 900,000 hospitalizations and more than 80,000 flu-related deaths

Acreage Holdings, Inc. (“Acreage”) (CSE: ACRG.U) and Form Factory, Inc. (“Form Factory”), a multi-state manufacturer and distributor of cannabis-based edibles and beverages, announced they have signed a definitive agreement for Acreage to acquire Form Factory, in an all-stock transaction valued at US$160 million.

WW collaborates with acclaimed “King of Comfort Food” to serve up 160 cozy WW Freestyle™ comfort food classics

Akero Therapeutics Inc., a biotechnology company developing transformational treatments for non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases, today announced the appointment of Mark Iwicki, chairman and CEO of Kala Pharmaceuticals, to Akero’s Board of Directors.

A new report released today by RealSelf, the leading online marketplace to learn about cosmetic treatments and connect with doctors and other clinicians, reveals the latest annual trends related to consumer interest in elective cosmetic treatments.